Jacques Izopet

发表

Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study. French Multicenter Study Group.

X. Causse, J. Izopet, Y. Bacq, 2000, Journal of hepatology.

CCR6− regulatory T cells blunt the restoration of gut Th17 cells along the CCR6–CCL20 axis in treated HIV-1-infected individuals

P. Massip, J. Izopet, C. Loiseau, 2016, Mucosal Immunology.

Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.

P. Massip, J. Izopet, S. Raymond, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France

J. Lefrère, F. Abravanel, F. Lionnet, 2016, Journal of viral hepatitis.

Hepatitis E: An emerging infection in high income countries.

J. Izopet, W. Irving, A. Hoepelman, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy

J. Izopet, J. Vinel, C. Bureau, 2007, Journal of viral hepatitis.

Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK/French study

L. Scobie, J. Izopet, A. Stanley, 2015, Alimentary pharmacology & therapeutics.

Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy

P. Marcellin, J. Pawlotsky, F. Roudot-thoraval, 1999, Journal of viral hepatitis.

Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial.

J. Izopet, J. Vinel, C. Bureau, 2001, Journal of hepatology.

Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France.

K. Nelson, A. Labrique, B. Basnyat, 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Pharmacokinetics of alphaIFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications.

L. Rostaing, J. Izopet, C. Thalamas, 1998, Journal of the American Society of Nephrology : JASN.

Hydroxychloroquine in COVID-19 patients: what still needs to be known about the kinetics

D. Concordet, J. Izopet, R. Guimbaud, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Transmissions of hepatitis C virus during the ancillary procedures for assisted conception.

J. Izopet, J. Parinaud, X. Monroziès, 2000, Human reproduction.